First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat

Getinge Group Sweden

View original content:https://www.prnewswire.co.uk/news-releases/first-patient-dosed-in-gesynta-pharmas-endometriosis-trial-of-vipoglanstat-302711084.html